speci
genu
bacteroid
import
constitu
human
anim
intestin
microbiota
compris
approxim
total
cultur
microorgan
fece
myer
et
al
mora
et
al
bacteroid
fragili
consid
import
clinic
pathogen
common
anaerob
isol
human
clinic
specimen
produc
endogen
infect
duerden
moreov
b
fragili
also
consid
virul
speci
genu
bacteroid
due
virul
factor
predomin
monomicrobi
mix
infect
brain
lung
intraabdomin
intrapelv
abscess
periton
sepsi
duerden
strain
b
fragili
etbf
produc
enterotoxin
caus
diarrhea
anim
also
associ
diarrhea
human
border
et
al
wu
et
al
extracellular
toxin
character
heatlabil
zincmetalloproteas
approxim
kda
member
matrix
metalloproteas
subfamili
metzincin
superfamili
moncrief
et
al
wu
et
al
acut
diarrhea
calv
within
first
month
life
becom
seriou
econom
problem
worldwid
caus
sever
damag
nation
livestock
due
delay
develop
grow
high
morbid
mortal
rate
infect
anim
classic
agent
produc
diarrhea
calv
includ
enterotoxigen
escherichia
coli
etec
rotaviru
cryptosporidium
almajali
et
al
yagita
et
al
howev
littl
known
role
intestin
anaerob
member
b
fragili
group
play
diarrhea
process
finegold
anim
cow
sheep
goat
use
milk
product
consum
meat
howev
practis
feed
anim
meat
bone
cattl
link
epidem
bovin
spongiform
encephalopathi
harm
prion
found
consum
anim
product
heavi
metal
persist
organ
pollut
exampl
metal
copper
use
extens
growthpromot
agent
industri
organ
anim
product
hasman
et
al
substanc
resist
degrad
releas
environ
accumul
food
web
often
end
consum
human
chemic
characterist
substanc
determin
locat
accumul
metabol
halflif
within
anim
tissu
member
b
fragili
group
studi
pathogen
potenti
unusu
multipl
resist
sever
antibiot
heavi
metal
salyer
avilacampo
et
al
nakano
avilacampo
transfer
within
speci
includ
gramneg
facult
anaerob
bacteria
e
coli
salyer
gupta
et
al
studi
occurr
enterotoxigen
nonenterotoxigen
speci
b
fragili
group
calv
without
diarrhea
evalu
well
suscept
isol
antibiot
metal
ion
one
hundr
eight
femal
calv
age
day
five
farm
around
citi
paulo
preto
paulo
brazil
examin
calv
drank
water
ad
libitum
none
treat
antibiot
prior
week
sampl
collect
calv
without
acut
diarrhea
select
studi
sex
use
select
criterion
stool
sampl
collect
calv
diarrhea
healthi
one
use
steril
rectal
swab
transport
caryblair
medium
lcysteinehcl
process
within
h
one
stool
sampl
taken
anim
ethic
commiss
anim
research
institut
biomed
scienc
univers
paulo
approv
studi
stool
sampl
plate
onto
select
b
agar
bbe
livingston
et
al
incub
h
one
three
coloni
stool
sampl
subcultur
trypticas
soy
agar
supplement
yeast
extract
mg
hemin
mg
menadion
defibrin
sheep
blood
identifi
use
api
kit
bacteria
belong
b
fragili
group
store
skim
milk
b
fragili
group
speci
assay
cytotox
effect
cell
describ
nakano
avilacampo
briefli
cell
grown
flask
ml
eagl
medium
glutamin
difco
supplement
penicillin
ui
streptomycin
inactiv
fetal
bovin
serum
incub
air
plu
cell
distribut
microtitr
plate
corn
us
allow
grow
assay
medium
remov
fresh
medium
without
serum
ad
supernat
ad
well
duplic
plate
incub
air
plu
examin
h
typic
toxininduc
cytotox
chang
occur
pantosti
et
al
bacteroidesfragili
atcc
enterotoxinposit
strain
use
control
one
coloni
mix
milliq
ultrapur
water
centrifug
twice
g
min
pellet
resuspend
ultrapur
water
boil
min
centrifug
g
min
supernat
use
templat
pcr
assay
moreov
mg
stool
sampl
wash
twice
ultrapur
water
process
describ
pcr
assay
perform
use
specif
primer
pair
accord
pantosti
invitrogen
brasil
ltd
paulo
sp
brazil
amplifi
characterist
fragment
amplif
perform
volum
contain
pcr
buffer
mm
mm
dntp
mixtur
invitrogen
u
taq
dna
polymeras
invitrogen
primer
templat
dna
amplif
perform
thermal
cycler
perkin
elmer
amp
pcr
system
program
min
follow
cycl
min
min
min
min
allow
dna
extens
neg
control
without
templat
includ
pcr
run
amplifi
product
analyz
electrophoresi
agaros
gel
tbe
buffer
tri
boric
acid
edta
ph
v
h
stain
ethidium
bromid
photograph
uv
light
transillumin
electrophoresi
document
analysi
system
kodak
digit
scienc
dna
ladder
molecular
marker
invitrogen
use
strain
produc
cytotox
chang
cell
harbor
bft
gene
defin
etbf
antibiot
use
follow
amoxicillin
ampicillin
clindamycin
tetracyclin
luper
ind
farm
ltd
paulo
sp
brazil
cefoxitin
imipenem
merck
sharp
dohm
paulo
sp
penicillin
g
prodoti
lab
farm
ltd
paulo
sp
tigecyclin
piperacillintazobactam
wyeth
philadelphia
pa
chloramphenicol
sigmaaldrich
sa
paulo
sp
moxifloxacin
bayer
corpor
west
ct
metronidazol
aventi
farm
ltd
paulo
sp
metal
use
follow
mercur
chlorid
silver
nitrat
copper
sulfat
nickel
sulfat
labsynth
prod
lab
ltd
paulo
sp
cadmium
sulfat
lead
chlorid
vetec
fina
ltd
paulo
sp
antibiot
suscept
test
perform
accord
clsi
use
agar
dilut
method
wilkinschalgren
agar
plate
contain
twofold
serial
dilut
antimicrobi
agent
rang
inocul
steer
replic
given
cfu
per
spot
plate
without
antibiot
metal
use
control
plate
incub
anaerob
h
minim
inhibitori
concentr
mic
defin
lowest
concentr
antimicrobi
agent
abl
inhibit
macroscop
bacteri
growth
antibiot
breakpoint
accord
clsi
metal
accord
riley
mee
avilacampo
refer
strain
b
fragili
atcc
b
fragili
gai
includ
experi
assess
reliabl
method
test
perform
duplic
penicillinresist
isol
test
verifi
product
use
hydrolysi
chromogen
cephalosporin
nitrocefin
method
oxoid
ltd
paulo
sp
briefli
drop
nitrocefin
deposit
microscop
slide
coloni
dissolv
mixtur
incub
room
temperatur
min
activ
express
neg
color
alter
observ
posit
red
color
note
bacteroid
fragili
atcc
use
control
member
b
fragili
group
observ
diarrhea
nondiarrhea
calv
total
bacteri
isol
recov
calv
diarrhea
isol
normal
stool
sampl
tabl
list
preval
speci
b
fragili
group
diarrhea
nondiarrhea
stool
bacteroid
vulgatu
b
fragili
bacteroid
distasoni
predomin
calv
group
bacteroid
eggerthii
observ
diarrhea
nondiarrhea
sampl
two
etbf
cytotox
cell
recov
diarrhea
stool
bacteroid
thetaitaomicron
bacteroid
ovatu
bacteroid
uniformi
bacteroid
cacca
observ
calv
diarrhea
also
harbor
bft
gene
fig
bft
gene
detect
four
diarrhea
sampl
alter
cell
produc
data
shown
four
stool
sampl
etbf
strain
isol
mic
valu
percentag
antibiot
metal
resist
given
tabl
respect
isol
test
resist
least
one
antibiot
test
amoxicillin
ampicillin
cefoxitin
penicillin
g
addit
isol
produc
enzym
isol
suscept
chloramphenicol
imipenem
moxifloxacin
piperacillintazobactam
metronidazol
tigecyclin
also
nondiarrhea
diarrhea
isol
suscept
clindamycin
tetracyclin
respect
isol
test
resist
metal
ion
investig
bacteria
isol
calv
diarrhea
show
low
level
resist
mercur
chlorid
higher
resist
lead
chlorid
moreov
bacteria
isol
calv
without
diarrhea
show
low
level
resist
mercur
chlorid
high
level
resist
nickel
sulfat
tabl
studi
presenc
member
b
fragili
group
farm
anim
particularli
calv
undertaken
brazil
result
show
high
preval
b
fragili
group
speci
anim
could
repres
endogen
sourc
differ
anaerob
infect
duerden
presenc
etbf
agent
acut
diarrhea
anim
observ
sever
countri
presenc
b
thetaiotaomicron
b
vulgatu
b
uniformi
b
cacca
etbf
strain
observ
calv
diarrhea
could
repres
possibl
bacteri
select
alter
intestin
microbiota
diarrhea
process
addit
observ
dna
obtain
four
stool
sampl
calv
diarrhea
harbor
bft
gene
howev
etbf
strain
isol
sampl
pcr
method
excel
tool
detect
bacteri
speci
mix
sampl
one
possibl
etbf
strain
present
nondetect
level
stool
sampl
supernat
four
sampl
produc
alter
cell
result
suggest
enteropathogen
rotaviru
coronaviru
salmonella
spp
enteropathogen
e
coli
etec
vibrio
cholera
could
implic
diarrhea
process
myer
et
al
enteropathogen
evalu
studi
antimicrobi
resist
anaerob
microorgan
increas
particularli
consid
resid
microbiota
use
antibiot
bovin
cattl
avoid
food
sourc
human
studi
test
bacteria
suscept
chloramphenicol
imipenem
moxifloxacin
piperacillintazobactam
metronidazol
tigecyclin
accord
snydman
aldridg
nakano
avilacampo
rossi
andreazzi
howev
bacteria
show
high
level
resist
antimicrobi
test
result
may
indic
anim
receiv
drug
food
soil
contamin
exampl
metal
ion
brazilian
studi
report
antimicrobi
suscept
speci
b
fragili
group
isol
human
callithrix
penicillata
marmoset
gastrointestin
tract
show
increas
resist
sever
drug
avilacampo
et
al
carvalho
et
al
pestana
et
al
high
frequenc
isol
predomin
b
fragili
calv
could
also
attribut
variabl
breed
condit
possibl
outsid
run
nonauthor
use
antimicrobi
growth
promot
limit
use
antimicrobi
therapi
age
slaughter
product
anaerob
import
mechan
resist
nord
hedberg
roger
et
al
isol
test
produc
enzym
resist
ampicillin
amoxicillin
cefoxitin
penicillin
g
moreov
enzym
chromosom
mediat
cephalosporinas
activ
mani
narrow
broadspectrum
penicillin
cephalosporin
rasmussen
et
al
suscept
b
fragili
isol
calv
may
exactli
reflect
suscept
human
patholog
strain
clindamycin
primari
choic
treatment
infect
produc
anaerob
bacteria
strain
test
studi
show
resist
antibiot
particularli
isol
diarrhea
bacteroid
fragili
isol
human
found
resist
clindamycin
nakano
avilacampo
betriu
et
al
snydman
et
al
hand
tetracyclin
show
activ
test
isol
cefoxitin
although
human
isol
cefoxitin
appear
effect
tetracyclin
paula
et
al
variat
resist
rate
found
studi
may
due
sourc
anim
use
antimicrobi
agent
differ
geograph
region
souza
et
al
variat
may
also
produc
bacteri
select
anim
microbiota
clone
mild
pathogen
may
contain
resist
gene
ie
tetracyclin
clindamycin
transfer
virul
b
fragili
strain
pathogen
bacteri
speci
salyer
shoemark
et
al
nakano
avilacampo
show
resist
antibiot
metal
ion
higher
children
diarrhea
isol
comparison
nondiarrhea
isol
recent
almeida
avilacampo
report
presenc
cepa
gene
plasmid
respons
resist
cefoxitin
b
fragili
isol
calv
diarrhea
suggest
genet
element
may
transfer
b
fragili
bacteri
speci
sensit
sever
drug
chloramphenicol
activ
isol
test
preserv
excel
activ
anaerob
bacteria
antibiot
good
tissu
penetr
use
treatment
case
benefit
exce
risk
toxic
wyho
et
al
moxifloxacin
report
activ
broad
spectrum
aerob
anaerob
bacteria
goldstein
et
al
also
report
penetr
accumul
human
gastrointestin
mucosa
wirtz
et
al
clsi
breakpoint
yet
establish
moxifloxacin
anaerob
bacteria
studi
chose
valu
accord
goldstein
howev
methodolog
media
use
evalu
moxifloxacin
activ
may
also
differ
due
geograph
factor
clonal
popul
sourc
isol
goldstein
et
al
piperacillintazobactam
remain
activ
inhibitor
combin
class
antibiot
remain
activ
b
fragili
group
data
show
tigecyclin
activ
b
fragili
strain
test
drug
exhibit
robust
activ
bacteri
strain
resist
variou
antibiot
class
includ
fluoroquinolon
howev
tigecyclin
use
monotherapi
seriou
infect
human
clinic
trial
anim
use
bauer
et
al
heavi
metal
wide
dispers
environ
inorgan
aggreg
chemic
substanc
metalloid
heavi
metal
food
repres
sever
risk
popul
longterm
toxicolog
effect
toxic
induc
excess
level
element
cadmium
lead
mercuri
well
known
llobet
et
al
bacteria
show
high
mic
valu
metal
ion
mainli
nickel
sulfat
lead
chlorid
resist
metal
ion
discuss
bacteria
may
relat
antibiot
resist
accord
riley
mee
data
regard
metal
suscept
b
fragili
group
bacteria
howev
metal
ion
resist
bacteria
gradual
increas
due
use
metal
industri
agricultur
hospit
medicin
nakano
avilacampo
result
show
variabl
suscept
metal
among
b
fragili
isol
diarrhea
nondiarrhea
calv
may
indic
ecolog
physiolog
alter
diarrheal
process
hand
bacteri
resist
metal
ion
may
repres
possibl
environment
contamin
soil
pastur
must
view
caution
cattl
serv
food
human
anim
allen
addit
food
contamin
metal
ancient
concern
given
transfer
quickli
food
chain
therefor
consid
endogen
origin
bacteria
conjug
transfer
properti
among
intestin
bacteria
result
concern
reaffirm
need
increas
surveil
antibiot
metal
resist
microbi
group
isol
anim
product
